Virology News and Research

Latest Virology News and Research

Transplacental passage of specific IgG in maternal SARS-CoV-2 infection

Researchers analyzed antibody profiles of mothers infected with SARS-CoV-2 and their offspring.

13 Sep 2022

Review of COVID-19 in children before and after SARS-CoV-2 Delta and Omicron variant emergence

Researchers provided a summary of SARS-CoV-2 infections among children pre- and post-SARS-CoV-2 Delta and Omicron variants of concern (VOCs) emergence.

12 Sep 2022

Researchers produce high-resolution crystal structure of enzyme critical to SARS-CoV-2 survival

A team of Mount Sinai researchers has produced a high-resolution crystal structure of an enzyme essential to the survival of SARS-CoV-2, the virus that causes COVID-19.

9 Sep 2022

MolGen Joins Life Sciences & Health Dutch Economic Mission to California

MolGen B.V. of Veenendaal (NL), participates in the 24th Annual Conference of the European Society for Clinical Virology (ESCV) held in Manchester, United Kingdom on 7-10 September 2022.

From MolGen 9 Sep 2022

SARS-CoV-2 infection leaves significant effects long after the patient is symptom-free

The immune cells of patients who received hospital care for COVID-19 early in the pandemic were still affected six months later.

8 Sep 2022

The virology, epidemiology, transmission, clinical manifestations, diagnosis, management, and prevention strategies associated with monkeypox

Scientists have described the epidemiology, transmission, clinical features, diagnosis, treatment, and preventive strategies of monkeypox infection among humans.

6 Sep 2022

Hand, foot and mouth disease afflicting children hyped up as 'tomato flu'

Leading clinicians and medical researchers in India say they are aghast at the media reports that portray hand, foot and mouth disease (HFMD) — a common, relatively mild, viral infection afflicting children — as caused by a new virus responsible for what is dubbed as 'tomato flu'.

5 Sep 2022

3 shots in 1: How microparticles could be used to deliver self-boosting vaccines

In this interview, we speak to Morteza Sarmadi from MIT about his labs latest research that developed microparticles able to deliver self-boosting vaccines.

30 Aug 2022

Viruses modify host cellular machinery to produce high amounts of viral progeny

The study, published in Nature Communications, shows a new mechanism whereby viruses modify cellular machinery so that it can better read the instructions in the genome of the invading virus.

29 Aug 2022

COVID-19 pandemic: An epidemiological update

Epidemics and pandemics have been frightening the human chase again and again. SARS, H1N1, Ebola, and more have exposed their real face in the past, but with every such outbreak.

25 Aug 2022

Study finds link between high-density lipoprotein and COVID-19

A new study has highlighted the significance of high-density lipoprotein COVID-19 pathogenesis and outcome.

24 Aug 2022

SARS-CoV-2 variants of concern emerging from chronic COVID infections, study shows

The coronavirus variants of concern are emerging from chronic, long-term COVID infections in people who may be immune comprised and unable to clear the virus, a new study strongly suggests.

23 Aug 2022

Marburg outbreak in Ghana causes African countries to stay alert

Africa must ramp up its surveillance and detection infrastructure in the light of an outbreak of the deadly Marburg virus in Ghana, public health leaders have warned.

23 Aug 2022

A practical guide for monkeypox diagnosis, prevention and treatment

Researchers provide an overview of the monkeypox infection in light of the current COVID-19 pandemic.

22 Aug 2022

Non-nutritive sweeteners cause changes in the gut microbes and impact glucose tolerance

Since the late 1800s non-nutritive sweeteners have promised to deliver all the sweetness of sugar with none of the calories.

19 Aug 2022

New study estimates how long people with mild COVID-19 are infectious

A new study of 57 people with mild COVID-19 estimates how long people are infectious for and when they can safely leave isolation.

19 Aug 2022

Acid ceramidase is a SARS-CoV-2 host factor, study says

Fluoxetine, a common antidepressant, inhibits the SARS-CoV-2 coronavirus in cell cultures and in preparations from human lung tissue. This was demonstrated by researchers at Julius-Maximilians-Universität (JMU) Würzburg in the summer of 2020. However, the mechanism of this inhibition was utterly unclear, so the teams continued their research.

17 Aug 2022

Study provides insights into understanding the biology of circulating Hepatitis E variants

Over three million people are infected with the hepatitis E virus every year. So far, no effective treatment is available. An international team has investigated which factors are important for the virus in the course of its replication cycle and how it manages to maintain the infection.